Literature DB >> 2121888

Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain.

E Puré1, K Inaba, M T Crowley, L Tardelli, M D Witmer-Pack, G Ruberti, G Fathman, R M Steinman.   

Abstract

Two prior studies with a small number of T cell lines have shown that the presentation of native protein antigens by epidermal Langerhans cells (LC) is regulated. When freshly isolated, LC are efficient antigen-presenting cells (APC), but after a period of culture LC are inefficient or even inactive. The deficit in culture seems to be a selective loss in antigen processing, since cultured LC are otherwise rich in major histocompatibility complex (MHC) class II products and are active APC for alloantigens and mitogens, which do not require processing. We have extended the analysis by studying presentation to bulk populations of primed lymph node and a T-T hybrid. Only freshly isolated LC can be pulsed with the protein antigens myoglobin and conalbumin, but once pulsed, antigen is retained in an immunogenic form for at least 2 d. The acquisition of antigen, presumably as MHC-peptide complexes, is inhibited if the fresh LC are exposed to foreign protein in the presence of chloroquine or cycloheximide. The latter, in contrast, improves the efficacy of antigen pulsing in anti-Ig-stimulated B blasts. In additional studies of mechanism, we noted that both fresh and cultured LC endocytose similar amounts of an antigen, rhodamineovalbumin, into perinuclear granules. However, freshly isolated LC synthesize high levels class II MHC molecules and express higher amounts of the class II-associated invariant chain. Fresh LC are at least 5-10 times more active than many other cells types in the level of biosynthesis of MHC class II products. These findings provide a physiologic model in which newly synthesized MHC class II molecules appear to be the principal vehicle for effective antigen processing by APC of the dendritic cell lineage. Another APC, the B lymphoblast, does not appear to require newly synthesized MHC class II molecules for presentation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121888      PMCID: PMC2188653          DOI: 10.1084/jem.172.5.1459

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  50 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Immunologic functions of Ia-bearing epidermal Langerhans cells.

Authors:  G Stingl; S I Katz; L Clement; I Green; E M Shevach
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

3.  Antigen-bearing langerhans cells in skin, dermal lymphatics and in lymph nodes.

Authors:  I Silberberg-Sinakin; G J Thorbecke; R L Baer; S A Rosenthal; V Berezowsky
Journal:  Cell Immunol       Date:  1976-08       Impact factor: 4.868

4.  Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells.

Authors:  H K Ziegler; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

5.  A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication.

Authors:  A Bhattacharya; M E Dorf; T A Springer
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

6.  Lymphocyte specificity to protein antigens. II. Fine specificity of T-cell activation with cytochrome c and derived peptides as antigenic probes.

Authors:  G Corradin; J M Chiller
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

7.  Lymphokine enhances the expression and synthesis of Ia antigens on cultured mouse peritoneal macrophages.

Authors:  R M Steinman; N Nogueira; M D Witmer; J D Tydings; I S Mellman
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

8.  Protein degradation in cultured cells. II. The uptake of chloroquine by rat fibroblasts and the inhibition of cellular protein degradation and cathepsin B1.

Authors:  M Wibo; B Poole
Journal:  J Cell Biol       Date:  1974-11       Impact factor: 10.539

9.  Contribution of dendritic cells to stimulation of the murine syngeneic mixed leukocyte reaction.

Authors:  M C Nussenzweig; R M Steinman
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

10.  Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ.

Authors:  K Inaba; J P Metlay; M T Crowley; R M Steinman
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

View more
  44 in total

1.  Endocytosis by antigen presenting cells: dendritic cells are as endocytically active as other antigen presenting cells.

Authors:  T P Levine; B M Chain
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

Review 2.  The immunologic properties of epidermal Langerhans cells as a part of the dendritic cell system.

Authors:  N Romani; G Schuler
Journal:  Springer Semin Immunopathol       Date:  1992

3.  Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture.

Authors:  E Kämpgen; N Koch; F Koch; P Stöger; C Heufler; G Schuler; N Romani
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

4.  Cultured human Langerhans' cells are superior to fresh cells at presenting native HIV-1 protein antigens to specific CD4+ T-cell lines.

Authors:  G Girolomoni; M T Valle; V Zacchi; M G Costa; A Giannetti; F Manca
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

5.  Tumor-immunotherapy with the use of tumor-antigen-pulsed antigen-presenting cells.

Authors:  J P Zou; J Shimizu; K Ikegame; H Takiuchi; H Fujiwara; T Hamaoka
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

6.  Antigen processing and CD24 expression determine antigen presentation by splenic CD4+ and CD8+ dendritic cells.

Authors:  David Askew; Clifford V Harding
Journal:  Immunology       Date:  2007-10-19       Impact factor: 7.397

7.  In vitro primary sensitization and restimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans' cells.

Authors:  C Moulon; J Péguet-Navarro; P Courtellemont; G Redziniak; D Schmitt
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

8.  Molecular cloning and expression of two chicken invariant chain isoforms produced by alternative splicing.

Authors:  Dalian Zhong; Weiyi Yu; Yuhua Liu; Jing Liu; Jinnian Li
Journal:  Immunogenetics       Date:  2004-11-16       Impact factor: 2.846

9.  Analysis of immunization route-related variation in the immune response to heat-killed Salmonella typhimurium in mice.

Authors:  J Thatte; S Rath; V Bal
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

10.  Role of epidermal Langerhans' cells in the induction of protective immunity to Schistosoma mansoni in guinea-pigs.

Authors:  H Sato; H Kamiya
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.